Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Kitamura

Showing results (201-210 of 240) with videos related to

Pageof 24
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Molecular basis of hematological malignancies]Toshio Kitamura, Daichi Inoue, Fumio Nakahara, et al.
Nature Communications|June 24, 2014
Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformationGoro Sashida, Hironori Harada, Hirotaka Matsui, et al.
Experimental Hematology|February 4, 2014
Hes1 upregulation contributes to the development of FIP1L1-PDGRA-positive leukemia in blast crisisTomoyuki Uchida, Jiro Kitaura, Fumio Nakahara, et al.
Cell Reports|August 25, 2021
A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cellsKeita Yamamoto, Susumu Goyama, Shuhei Asada, et al.
Leukemia|July 18, 2023
SETBP1 is dispensable for normal and malignant hematopoiesisAtsushi Tanaka, Koutarou Nishimura, Wataru Saika, et al.
Nature Communications|July 18, 2018
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesisShuhei Asada, Susumu Goyama, Daichi Inoue, et al.
Leukemia|February 25, 2020
PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphomaMasaharu Kawashima, Joaquim Carreras, Hiroshi Higuchi, et al.
Nature Communications|February 17, 2026
Recruitment of BRD4 to the ASXL1 genomic targets depends on the extra-terminal domain of BRD4Karthik Selvam, Shuang Lu, Clémence Messmer, et al.
Cell Reports|December 19, 2019
Discrimination of Dormant and Active Hematopoietic Stem Cells by G<sub>0</sub> Marker Reveals Dormancy Regulation by Cytoplasmic CalciumTsuyoshi Fukushima, Yosuke Tanaka, Fiona K Hamey, et al.
The Journal of Experimental Medicine|April 13, 2018
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformationReina Nagase, Daichi Inoue, Alessandro Pastore, et al.
Pageof 24

Showing results (201-210 of 240) with videos related to

Sort By:
Pageof 24
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Molecular basis of hematological malignancies]Toshio Kitamura, Daichi Inoue, Fumio Nakahara, et al.
Nature Communications|June 24, 2014
Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformationGoro Sashida, Hironori Harada, Hirotaka Matsui, et al.
Experimental Hematology|February 4, 2014
Hes1 upregulation contributes to the development of FIP1L1-PDGRA-positive leukemia in blast crisisTomoyuki Uchida, Jiro Kitaura, Fumio Nakahara, et al.
Cell Reports|August 25, 2021
A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cellsKeita Yamamoto, Susumu Goyama, Shuhei Asada, et al.
Leukemia|July 18, 2023
SETBP1 is dispensable for normal and malignant hematopoiesisAtsushi Tanaka, Koutarou Nishimura, Wataru Saika, et al.
Nature Communications|July 18, 2018
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesisShuhei Asada, Susumu Goyama, Daichi Inoue, et al.
Leukemia|February 25, 2020
PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphomaMasaharu Kawashima, Joaquim Carreras, Hiroshi Higuchi, et al.
Nature Communications|February 17, 2026
Recruitment of BRD4 to the ASXL1 genomic targets depends on the extra-terminal domain of BRD4Karthik Selvam, Shuang Lu, Clémence Messmer, et al.
Cell Reports|December 19, 2019
Discrimination of Dormant and Active Hematopoietic Stem Cells by G<sub>0</sub> Marker Reveals Dormancy Regulation by Cytoplasmic CalciumTsuyoshi Fukushima, Yosuke Tanaka, Fiona K Hamey, et al.
The Journal of Experimental Medicine|April 13, 2018
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformationReina Nagase, Daichi Inoue, Alessandro Pastore, et al.
Pageof 24